Welcome to the Website for RIGHT Statement

News

Checklist

Extensions

Members

Translations

Glossary

RIGHT Checklist

Section/topicNo.Item
Basic information
Title/subtitle1aIdentify the report as a guideline, that is, with “guideline(s)” or “recommendation(s)” in the title.
1bDescribe the year of publication of the guideline.
1cDescribe the focus of the guideline, such as screening, diagnosis, treatment, management, prevention, or others.
Executive summary2Provide a summary of the recommendations contained in the guideline.
Abbreviations and acronyms3Define new or key terms, and provide a list of abbreviations and acronyms if applicable.
Corresponding developer4Identify at least 1 corresponding developer or author who can be contacted about the guideline.
Background
Brief description of the health problem(s)5Describe the basic epidemiology of the problem, such as the prevalence/incidence, morbidity, mortality, and burden (including financial) resulting from the problem.
Aim(s) of the guideline and specific objectives6Describe the aim(s) of the guideline and specific objectives, such as improvements in health indicators (e.g., mortality and disease prevalence), quality of life, or cost savings.
Target population(s)7aDescribe the primary population(s) that is affected by the recommendation(s) in the guideline.
7bDescribe any subgroups that are given special consideration in the guideline.
End users and settings8aDescribe the intended primary users of the guideline (such as primary care providers, clinical specialists, public health practitioners, program managers, and policymakers) and other potential users of the guideline.
8bDescribe the setting(s) for which the guideline is intended, such as primary care, low- and middle-income countries, or inpatient facilities.
Guideline development groups9aDescribe how all contributors to the guideline development were selected and their roles and responsibilities (e.g., steering group, guideline panel, external reviewer, systematic review team, and methodologists).
9bList all individuals involved in developing the guideline, including their title, role(s) and institutional affiliation(s).
Evidence
Health care questions10aState the key questions that were the basis for the recommendations in PICO (population, intervention, comparator, and outcome) or other format as appropriate.
10bIndicate how the outcomes were selected and sorted.
Systematic reviews11aIndicate whether the guideline is based on new systematic reviews done specifically for this guideline or whether existing systematic reviews were used.
11bIf the guideline developers used existing systematic reviews, reference these and describe how those reviews were identified and assessed (provide the search strategies and the selection criteria, and describe how the risk of bias was evaluated) and whether they were updated.
Assessment of the certainty of the body of evidence12Describe the approach used to assess the certainty of the body of evidence.
Recommendations
Recommendations13aProvide clear, precise, and actionable recommendations.
13bPresent separate recommendations for important subgroups if the evidence suggests that there are important differences in factors influencing recommendations, particularly the balance of benefits and harms across subgroups.
13cIndicate the strength of recommendations and the certainty of the supporting evidence.
Rationale/explanation for recommendations14aDescribe whether values and preferences of the target population(s) were considered in the formulation of each recommendation. If yes, describe the approaches and methods used to elicit or identify these values and preferences. If values and preferences were not considered, provide an explanation.
14bDescribe whether cost and resource implications were considered in the formulation of recommendations. If yes, describe the specific approaches and methods used (such as cost-effectiveness analysis) and summarize the results. If resource issues were not considered, provide an explanation.
14cDescribe other factors taken into consideration when formulating the recommendations, such as equity, feasibility and acceptability.
Evidence to decision processes15Describe the processes and approaches used by the guideline development group to make decisions, particularly the formulation of recommendations (such as how consensus was defined and achieved and whether voting was used).
Review and quality assurance
External review16Indicate whether the draft guideline underwent independent review and, if so, how this was executed and the comments considered and addressed.
Quality assurance17Indicate whether the guideline was subjected to a quality assurance process. If yes, describe the process.
Funding, declaration and management of interests
Funding source(s) and role(s) of the funder18aDescribe the specific sources of funding for all stages of guideline development.
18bDescribe the role of funder(s) in the different stages of guideline development and in the dissemination and implementation of the recommendations.
Declaration and management of interest19aDescribe what types of conflicts (financial and nonfinancial) were relevant to guideline development.
19bDescribe how conflicts of interest were evaluated and managed and how users of the guideline can access the declarations.
Other information
Access20Describe where the guideline, its appendices, and other related documents can be accessed.
Suggestions for further research21Describe the gaps in the evidence and/or provide suggestions for future research.
Limitations of the guideline22Describe any limitations in the guideline development process (such as the development groups were not multidisciplinary or patients’ values and preferences were not sought), and indicate how these limitations might have affected the validity of the recommendations.

 

From: Chen Yaolong, Yang Kehu, Marušić A, et al. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement[J]. Ann Intern Med. 2017;166:128-132. doi: 10.7326/M16-1565.